Abbott India shares jump 6% after Q3 net profit jumps 16% to Rs 361 crore

Pharma

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

The shares of Abbott India jumped over 6 percent on February 5 after the company reported a 16 percent year-on-year rise in net profit for the quarter which ended on December 31, 2024. The shares closed at Rs 27,770 apiece.

Abbott India announced its results of the October-December quarter in an exchange filing on February 5. The pharma company reported a net profit of Rs 360.78 crore for the reported quarter. This marks a rise of nearly 16 percent from the Rs 310.98 crore net profit reported in Q3 of the previous financial year.

Its revenue from operations rose 12 percent to Rs 1,614.28 crore in Q3 of the current financial year. The company had earlier reported revenue from operations at Rs 1,437.14 crore for Q3 of the previous financial year.

Abbott India's total income meanwhile rose to Rs 1,686.03 crore in Q3 FY25 from Rs 1,492.75 in Q3 FY24. Its total expenses also rose to Rs 1,198.44 crore during the reported quarter.

Also read: Our LIVE blog on Q3 results

Along with the Q3 results, the pharma company announced that it has reappointed Deloitte Touche Tohmatsu India LLP, Chartered Accountants as Internal Auditors of the company for the next financial year (FY26) which begins from April, 2025. The company has also appointed Harshraj Madan as the Commercial Director of its GI Business, who will be part of the senior management team of the company. His appointment will be effective from February 17, 2025.

Notably, around 124 companies are announcing their results for the October-December quarter of the current financial year on February 5. Swiggy, Naukri-parent Info Edge, Black Buck, Eveready Industries, Reliance Power, Sagility, Skipper and Zydus Lifesciences are some of the notable names among them.